![Karrin Powys-Lybbe](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3067753/4da7d465-24f9-48d4-b52c-7d8868de2734/profile.png)
Karrin Powys-Lybbe
Global Guide 2024
Band 4 : Corporate/M&A
Email address
[email protected]Contact number
+1 416 865 7829Share profile
About
Provided by Karrin Powys-Lybbe
Practice Areas
Karrin advises on some of the most sophisticated and high-profile M&A and securities transactions in Canada. With a rigorous, creative and practical approach, Karrin builds lasting relationships with her clients, guiding them through their long-term objectives and strategies.
Karrin is co-head of the firm's M&A practice with a broad practice supporting clients across mergers and acquisitions, securities law, corporate finance and corporate governance. She is a long-time trusted advisor to many clients, including companies in the Brookfield group.
Karrin is the former managing partner of Torys’ New York office and a former member of Torys’ Executive Committee.
Articles, highlights and press releases
4 items provided by Torys LLP
On its face, record-breaking M&A levels in Canada in 2021 appear to be setting the stage for an eventful year in deal-making in 2022. However, deal activity is only part of the story of 2021 for dealmakers in Canada. M&A this year will be shaped by a diverse range of drivers.
As the COVID-19 vaccination program rolls out nationwide, corporate Canada’s decision-makers are putting domestic and cross-border growth plans to work. This article examines domestic and international merger trends and opportunities within a changed post-pandemic business environment.
Although many businesses put their M&A plans on hold at the beginning of COVID-19, deal activity significantly rebounded in the second half of the year. Parties successfully overcame numerous unprecedented challenges. This article surveys Canadian M&A activity in 2020 and previews the upcoming year.
Torys Quarterly: Redefining M&A strategy for the post-pandemic world
Business leaders across the globe have focused foremost on continuity concerns amid the COVID-19 crisis.
On its face, record-breaking M&A levels in Canada in 2021 appear to be setting the stage for an eventful year in deal-making in 2022. However, deal activity is only part of the story of 2021 for dealmakers in Canada. M&A this year will be shaped by a diverse range of drivers.
As the COVID-19 vaccination program rolls out nationwide, corporate Canada’s decision-makers are putting domestic and cross-border growth plans to work. This article examines domestic and international merger trends and opportunities within a changed post-pandemic business environment.
Although many businesses put their M&A plans on hold at the beginning of COVID-19, deal activity significantly rebounded in the second half of the year. Parties successfully overcame numerous unprecedented challenges. This article surveys Canadian M&A activity in 2020 and previews the upcoming year.
Torys Quarterly: Redefining M&A strategy for the post-pandemic world
Business leaders across the globe have focused foremost on continuity concerns amid the COVID-19 crisis.
Discover other Lawyers at
Torys LLP
Canada
![Frank Iacobucci](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3068442/4d3f29a0-f5eb-4f72-a274-5d4fb0ec9ab5/profile.png)
![Valerie Helbronner](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3068207/ef14c983-505c-493b-a037-0e88430d6add/profile.png)
![Adam E Delean](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3066744/19f1e479-3fdd-4b0c-ab44-f6d784975b5b/profile.png)
![Amanda Balasubramanian](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3066760/4143ab52-85a6-497e-843c-31c6e1b5d159/profile.png)
![Kevin A Fougere](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3066843/d08d6b1e-88b3-4fa4-b79e-78548e2f86f4/profile.png)
![Tom Zverina](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3067133/7876147e-1e15-42d5-a324-d2ba7a640cba/profile.png)
![Blair W Keefe](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3066664/e7a67212-9677-40b5-b9da-fa745e31acba/profile.png)
![Glen R Johnson](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3066544/0a148b85-e841-43f1-aef2-d1d566448781/profile.png)
![Rima Ramchandani](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3261835/a38b3e4b-f24f-4ee6-9639-3de2035e886b/profile.png)
![Scott Cochlan](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3066582/a63f51af-3371-4782-a8b5-0b183006c962/profile.png)
![Matthew W Cockburn](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3067754/818a4954-41fe-470c-8d55-da999ab3092a/profile.png)
![John Emanoilidis](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3067854/4479b7b1-f247-450e-a4f5-0862ffd1e5af/profile.png)
![Karrin Powys-Lybbe](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3067753/4da7d465-24f9-48d4-b52c-7d8868de2734/profile.png)
![Don Bell](https://assets-cdn.chambers.com/cdn-cgi/image/format=auto,fit=scale-down/https://media.chambers.com/individuals/3068293/6e41cc04-c45a-4c07-ab27-076a074f2d09/profile.png)